Next generation sequencing technologies have greatly reduced the barrier for whole genome sequencing, which enables systematic survey of the entire mutation spectrum of human cancer samples. In collaboration with Complete Genomics, we sequenced and compared the tumor and normal tissue of a 51 year old Caucasian male with non-small cell lung cancer. The patient's primary lung tumor was sequenced...